Zoetis INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Kristin C Peck, Chief Executive Officer and a Director of Zoetis Inc., received 720 shares of common stock on October 9, 2026.
NYSE
Kevin Esch, Executive Vice President of Zoetis Inc., received 360 shares of common stock on October 9, 2026.
NYSE
Rimma Driscoll, Executive Vice President of Zoetis Inc., received 278 shares of common stock on October 9, 2026.
NYSE
Julie Fuller, Executive Vice President of Zoetis Inc., received 368 shares of common stock on October 9, 2026.
NYSE
Keith Sarbaugh, Executive Vice President of Zoetis Inc., received 303 shares of common stock on October 9, 2026.
NYSE
Astorga Jeannette Ferran, Executive Vice President of Zoetis Inc., received 53 shares of common stock on October 9, 2026.
NYSE
Abhay U Nayak, Executive Vice President of Zoetis Inc., received 321 shares of common stock on October 9, 2026.
NYSE
Roxanne Lagano, Executive Vice President of Zoetis Inc., received 368 shares of common stock on October 9, 2026.
NYSE
Julie Fuller, Executive Vice President of Zoetis Inc., reported multiple transactions in common stock on September 30, 2026.
NYSE
Mark Stetter, a Director of Zoetis Inc., received 342 shares of common stock on September 17, 2026.
NYSE
James Saccaro, EVP, CFO & COO of Zoetis Inc., received 81,063 shares of common stock on August 31, 2026.
NYSE
Frank A Damelio, a Director of Zoetis Inc., reported a transaction in 6,650 shares of common stock on August 7, 2026.
NYSE
Keith Sarbaugh, Executive Vice President of Zoetis Inc., received 260 shares of common stock on July 10, 2026.
NYSE
Kristin C Peck, Chief Executive Officer and a Director of Zoetis Inc., received 616 shares of common stock on July 10, 2026.
NYSE
Abhay U Nayak, Executive Vice President of Zoetis Inc., received 215 shares of common stock on July 10, 2026.
NYSE
Kevin Esch, Executive Vice President of Zoetis Inc., received 308 shares of common stock on July 10, 2026.
NYSE
Rimma Driscoll, Executive Vice President of Zoetis Inc., received 238 shares of common stock on July 10, 2026.
NYSE
Julie Fuller, Executive Vice President of Zoetis Inc., received 315 shares of common stock on July 10, 2026.
NYSE
Roxanne Lagano, Executive Vice President of Zoetis Inc., received 315 shares of common stock on July 10, 2026.
NYSE
Astorga Jeannette Ferran, Executive Vice President of Zoetis Inc., received 45 shares of common stock on July 10, 2026.
NYSE
Wetteny Joseph, Chief Financial Officer of Zoetis Inc., received 363 shares of common stock on July 10, 2026.
NYSE
Director Michael B. McCallister transferred 1,209 shares of Zoetis common stock to a family trust.
NYSE
Zoetis Inc. Director Mark Stetter reported the acquisition of 1,572 shares of common stock upon the vesting of restricted stock units.
NYSE
Zoetis Inc. director Louise M. Parent reported transactions involving the acquisition of common stock through the settlement of restricted and deferred stock units upon her retirement from the board.
NYSE
Zoetis Inc. Director Frank A. Damelio acquired 6,650 shares of common stock on May 13, 2026, at a price of $75.39 per share.
NYSE
Zoetis Inc. director Paul Bisaro reported the acquisition of 2,000 shares of common stock on May 13, 2026.
NYSE
Zoetis Inc. Director Michael B. McCallister purchased 3,000 shares of common stock at a weighted average price of $77.7578.
NYSE
Executive Vice President Kevin Esch acquired 259 shares of Zoetis Inc. common stock following the vesting of restricted stock units.
NYSE
Julie Fuller, Executive Vice President at Zoetis Inc., reported transactions involving phantom stock units and common stock.
NYSE
Roxanne Lagano, Executive Vice President at Zoetis Inc., acquired phantom stock units under a savings plan.